The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes

The Journal of Clinical Investigation
S E Malawista, P T Bodel

Abstract

The effect of colchicine on the uptake of oxygen by human leukocytes during phagocytosis of live streptococci or of killed staphylococci was compared with the effect of colchicine on phagocytosis per se, measured in a sensitive bacterial system. The increase in oxygen consumption that normally accompanies phagocytosis was consistently diminished in leukocytes incubated with colchicine in concentrations as low as 2.5 x 10(-6) mole per L (1 mug per ml), and this inhibition was dosage dependent. Yet there was no evidence of decreased phagocytosis with concentrations of colchicine as high as 2.5 x 10(-4) mole per L (100 mug per ml). Furthermore, with measurements at 20, 40, and 60 minutes, the rate of phagocytosis was comparable with and without colchicine.A clue to the dissociation between oxygen consumption and phagocytosis was found in rapidly dried preparations of the incubated leukocytes. Ingested bacteria were present in both control and colchicine-treated granulocytes. In addition, control cells showed normal loss of granules (lysosomal particles) and prominent cytoplasmic vacuoles (digestive vacuoles). Colchicine-treated cells, however, showed less such degranulation and vacuolization. Measurements of granule-associated aci...Continue Reading

References

Oct 1, 1965·Arthritis and Rheumatism·S L Wallace
Oct 1, 1965·Arthritis and Rheumatism·S E Malawista
Oct 1, 1965·Arthritis and Rheumatism·J E Caner
Dec 1, 1965·Arthritis and Rheumatism·S E GoldfingerJ E Seegmiller
Dec 1, 1960·The Journal of Experimental Medicine·Z A COHN, J G HIRSCH
Dec 1, 1960·The Journal of Experimental Medicine·J G HIRSCH, Z A COHN
Mar 1, 1961·Annals of Internal Medicine·D J MCCARTY, J L HOLLANDER
Sep 1, 1959·The Journal of Experimental Medicine·Z A COHN, S I MORSE
Jun 1, 1963·The Journal of Cell Biology·R ORENM L KARNOVSKY
Feb 1, 1963·Canadian Journal of Biochemistry and Physiology·G Y IYER, J H QUESTEL
Dec 1, 1962·Arthritis and Rheumatism·J E SEEGMILLER, R R HOWELL
Oct 1, 1963·The Journal of Pathology and Bacteriology·D B BREWER
Jan 1, 1964·Proceedings of the Society for Experimental Biology and Medicine·L THOMAS
Oct 1, 1964·The Journal of Experimental Medicine·D ZUCKER-FRANKLIN, J G HIRSCH
Oct 17, 1964·Nature·R H CAGAN, M L KARNOVSKY
Aug 1, 1965·The Journal of Experimental Medicine·S E MALAWISTA
Aug 1, 1961·Proceedings of the Society for Experimental Biology and Medicine·L J KRENIS, B STRAUSS

❮ Previous
Next ❯

Citations

Sep 1, 1970·Arthritis and Rheumatism
Nov 1, 1975·Arthritis and Rheumatism·S E Malawista
Nov 1, 1975·Arthritis and Rheumatism·S L Wallace
Dec 1, 1980·European Journal of Pediatrics·M RisterE Gladtke
Oct 1, 1974·Agents and Actions·L J Ignarro
Oct 15, 1972·Biochemical Pharmacology·A Karan, P T Ozand
Aug 15, 1976·Biochemical Pharmacology·W A Creasey
May 2, 1968·The New England Journal of Medicine·P G QuieS E Malawista
Oct 17, 1968·The New England Journal of Medicine·R W Kellermeyer, R C Graham
Jun 13, 1974·The New England Journal of Medicine·R W Ortel, D S Newcombe
Oct 31, 1974·The New England Journal of Medicine·C A DinarelloD W Alling
Nov 28, 1974·The New England Journal of Medicine·M J Cline
Aug 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·S A RudolphS E Malawista
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·K D BrownE Rozengurt
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R Tauber, W Reutter
Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S E Malawista, G Van Blaricom
Jan 1, 1969·The Journal of Cell Biology·R H MichellM L Karnovsky
Jan 1, 1969·The Journal of Cell Biology·K G Bensch, S E Malawista
Jun 1, 1978·The Journal of Cell Biology·R D Berlin, J M Oliver
Jun 1, 1978·The Journal of Cell Biology·S E MalawistaS A Rudolph
Dec 1, 1982·The Journal of Cell Biology·S E Malawista, A De Boisfleury Chevance
Feb 1, 1969·The Journal of Experimental Medicine·C E McCallM Finland
Jul 1, 1972·The Journal of Experimental Medicine·T E Ukena, R D Berlin
Aug 1, 1973·The Journal of Experimental Medicine·A OronskyR Perper
May 1, 1975·The Journal of Experimental Medicine·E L Pesanti, S G Axline
Oct 1, 1975·The Journal of Experimental Medicine·E L Pesanti, S G Axline
May 1, 1976·The Journal of Experimental Medicine·P Bodel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.